In recent years, there has been a growing recognition of the effectiveness of innovative financing mechanisms in addressing funding shortfalls for market-driven solutions targeting social challenges. Such mechanisms can help battling antimicrobial resistance, which is an urgent and critical priority, especially ensuring rapid and precise diagnostics in underserved areas, writes healthcare veteran Dr Harsh Mahajan and IPE Global’s Ashwajit Singh.
M.K. Padma Kumar is involved in developing strategies and managing operations for the IPE Global Group.
He has over 25 years of experience in the development sector, working in civil society organisations and international development agencies like DANIDA and DFID. As the Head of State Partnerships at the DFID India, he was responsible for developing partnerships, programme design, management and strategic oversight of all programmes implemented in Bihar, Madhya Pradesh and Odisha. He has managed various development programmes. His expertise lies in driving operational, financial and programmatic transformations. Before DFID, he was associated with Danish International Development Agency (DANIDA), Help Age and World Wildlife Fund.
He holds a Master’s degree in Business Management with specialisation in Human Resource Management and Finance. He is extensively trained in Project Cycle Management, Grant Management, Performance Management, Leadership Skills and Change Management.
